Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21

Nature Chemical Biology

Volumn 7, Issue 4, 2011, Pages 214-221

  Wang, Yuefeng ^a   Fisher, John C ^a,b,c   Mathew, Rose ^a   Ou, Li ^a   Otieno, Steve ^a   Sublet, Jack ^a   Xiao, Limin ^a   Chen, Jianhan ^d   Roussel, Martine F ^a,b   Kriwacki, Richard W ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^d KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN P21; PROTEIN P27;

ARTICLE; BIOCHEMISTRY; CELL CYCLE REGULATION; CELL DIVISION; CONSERVATION BIOLOGY; EUKARYOTE; EUKARYOTIC CELL; GENETIC VARIABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION;

EUKARYOTA;

EID: 79952959945     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.536     Document Type: Article

References (49)

1. Anfinsen, C.B. Principles that govern the folding of protein chains. Science 181, 223-230 (1973).
2. Martin, A.C. et al. Protein folds and functions. Structure 6, 875-884 (1998). (Pubitemid 28348650)
3. Dyson, H.J. & Wright, P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6, 197-208 (2005). (Pubitemid 40314921)
4. Dunker, A.K., Obradovic, Z., Romero, P., Garner, E.C. & Brown, C.J. Intrinsic protein disorder in complete genomes. Genome Inform. Ser. Workshop Genome Inform. 11, 161-171 (2000).
5. Dyson, H.J. & Wright, P.E. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12, 54-60 (2002). (Pubitemid 34142721)
6. Lacy, E.R. et al. p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nat. Struct. Mol. Biol. 11, 358-364 (2004). (Pubitemid 38436801)
7. Kriwacki, R.W., Hengst, L., Tennant, L., Reed, S.I. & Wright, P.E. Structural studies of p21(waf1/cip1/sdi1) in the free and Cdk2-bound state: Conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA 93, 11504-11509 (1996).
8. Tompa, P., Szasz, C. & Buday, L. Structural disorder throws new light on moonlighting. Trends Biochem. Sci. 30, 484-489 (2005). (Pubitemid 41206503)
9. Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163 (1995).
10. Morgan, D.O. Principles of CDK regulation. Nature 374, 131-134 (1995).
11. Weinbeg, R.A. The Biology of Cancer, (Garland Science, London, 2006).
12. Xiong, Y. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704 (1993). (Pubitemid 24036020)
13. Harper, J.W. et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400 (1995).
14. Zhang, H., Xiong, Y. & Beach, D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4, 897-906 (1993). (Pubitemid 23309425)
15. Cheng, M. et al. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583 (1999). (Pubitemid 29127070)
16. Galea, C.A., Wang, Y., Sivakolundu, S.G. & Kriwacki, R.W. Regulation of cell division by intrinsically unstructured proteins: Intrinsic flexibility, modularity, and signaling conduits. Biochemistry 47, 7598-7609 (2008). (Pubitemid 352019491)
17. Russo, A.A., Jeffrey, P.D., Patten, A.K., Massague, J. & Pavletich, N.P. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331 (1996). (Pubitemid 26260452)
18. Wang, Y., Filippov, I., Richter, C., Luo, R. & Kriwacki, R.W. Solution NMR studies of an intrinsically unstructured protein within a dilute, 75 kDa eukaryotic protein assembly; probing the practical limits for efficiently assigning polypeptide backbone resonances. ChemBioChem 6, 2242-2246 (2005).
19. Schwarzinger, S. et al. Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 123, 2970-2978 (2001). (Pubitemid 32879567)
20. Wishart, D.S. & Sykes, B.D. Chemical shifts as a tool for structure determination. Methods Enzymol. 239, 363-392 (1994).
21. Kriwacki, R.W., Wu, J., Siuzdak, G. & Wright, P.E. Probing protein/protein interactions with mass spectrometry and isotopic labeling: Analysis of the p21/Cdk2 complex. J. Am. Chem. Soc. 118, 5320-5321 (1996). (Pubitemid 26201556)
22. Harper, J.W. et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400 (1995).
23. Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics 22, 195-201 (2006). (Pubitemid 43205406)
24. Creighton, T.E. (ed.). Protein Structure, A Practical Approach, (IRL Press, New York, 1989).
25. Schulman, B.A., Lindstrom, D.L. & Harlow, E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc. Natl. Acad. Sci. USA 95, 10453-10458 (1998). (Pubitemid 28413088)
26. Lacy, E.R. et al. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division. J. Mol. Biol. 349, 764-773 (2005). (Pubitemid 40725953)
27. Bowman, P., Galea, C.A., Lacy, E. & Kriwacki, R.W. Thermodynamic characterization of interactions between p27(Kip1) and activated and non-activated Cdk2: Intrinsically unstructured proteins as thermodynamic tethers. Biochim. Biophys. Acta 1764, 182-189 (2006).
28. Grimmler, M. et al. Cdk-inhibitory activity and stability of p27(Kip1) are directly regulated by oncogenic tyrosine kinases. Cell 128, 269-280 (2007). (Pubitemid 46123508)
29. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433 (1998). (Pubitemid 28371361)
30. Sherr, C.J. & Roberts, J.M. Cdk inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999). (Pubitemid 29297917)
31. Hirai, H., Roussel, M.F., Kato, J.Y., Ashmun, R.A. & Sherr, C.J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681 (1995).
32. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. & Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993). (Pubitemid 23346377)
33. Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501 (1998). (Pubitemid 28538613)
34. Galea, C.A. et al. Role of intrinsic flexibility in signal transduction mediated by the cell cycle regulator, p27 Kip1. J. Mol. Biol. 376, 827-838 (2008).
35. Sherr, C.J. & Roberts, J.M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18, 2699-2711 (2004). (Pubitemid 39507762)
36. Brown, N.R. et al. Cyclin B and cyclin A confer different substrate recognition properties on CDK2. Cell Cycle 6, 1350-1359 (2007). (Pubitemid 47327970)
37. Honda, R. et al. The structure of cyclin E1/CDK2: Implications for CDK2 activation and CDK2-independent roles. EMBO J. 24, 452-463 (2005). (Pubitemid 40343248)
38. Day, P.J. et al. Crystal structure of human CDK4 in complex with a D-type cyclin. Proc. Natl. Acad. Sci. USA 106, 4166-4170 (2009).
39. Takaki, T. et al. The structure of CDK4/cyclin D3 has implications for models of CDK activation. Proc. Natl. Acad. Sci. USA 106, 4171-4176 (2009).
40. Mittag, T. & Forman-Kay, J.D. Atomic-level characterization of disordered protein ensembles. Curr. Opin. Struct. Biol. 17, 3-14 (2007). (Pubitemid 46240819)
41. Sivakolundu, S.G., Bashford, D. & Kriwacki, R.W. Disordered p27(Kip1) exhibits intrinsic structure resembling the Cdk2/Cyclin A-bound conformation. J. Mol. Biol. 353, 1118-1128 (2005). (Pubitemid 41503276)
42. Neidhardt, F.C., Bloch, P.L. & Smith, D.F. Culture medium for enterobacteria. J. Bacteriol. 119, 736-747 (1974).
43. Creighton, T.E. Proteins: Structures and Molecular Properties, (W. H. Freeman & Co., New York, NY, 1993).
44. Zhou, P., Lugovskoy, A.A. & Wagner, G. A solubility-enhancement tag (SET) for NMR studies of poorly behaving proteins. J. Biomol. NMR 20, 11-14 (2001). (Pubitemid 32519649)
45. Schwarzinger, S. et al. Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 123, 2970-2978 (2001). (Pubitemid 32879567)
46. Zhu, G., Xia, Y., Nicholson, L.K. & Sze, K.H. Protein dynamics measurements by TROSY-based NMR experiments. J. Magn. Reson. 143, 423-426 (2000).
47. Delaglio, F. et al. NMR Pipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293 (1995).
48. Cavanagh, J., Fairbrother, W.J., Palmer, A.G. III, Rance, M. & Skelton, N.J. Protein NMR spectroscopy: Principle and Practice, (Academic Press, New York, 2007).
49. Bowman, P., Galea, C.A., Lacy, E. & Kriwacki, R.W. Thermodynamic characterization of interactions between p27(Kip1) and activated and non-activated Cdk2: Intrinsically unstructured proteins as thermodynamic tethers. Biochim. Biophys. Acta 1764, 182-189 (2006).